
TSE:L
This summary was created by AI, based on 15 opinions in the last 12 months.
Loblaw Companies Ltd. is Canada's leading food and drug retailer, effectively navigating challenges posed by inflation and competition. Analysts commend its strategic focus on discount formats like No Frills and the strong performance of its private labels, particularly the No Name brand. The acquisition of Shoppers Drug Mart has proven beneficial, generating robust free cash flow, and establishing a solid market position with organic growth prospects. While some experts express concerns about its current valuation being high, the company remains a reliable defensive choice in uncertain economic times. Overall, experts acknowledge its significant market share, operational efficiencies, and impressive revenue growth despite mixed sentiment regarding its valuation relative to competitors.
Competition is fierce from Walmart, Costco, Amazon. Has come up since it's in consumer staples. Low beta, decent dividend, but not a lot of growth ahead of it. He'd look at Dollarama or Couche-Tarde instead. Also, Ontario minimum wage increase has been a detriment.
Their on-line offering will not be threatened by AMZN-Q's grocery delivery.